Amoxicillin Capsules, USP, 500 mg, 100-count bottle, Rx only, MFG: Sandoz Pharma, NDC 0781-2613-01
Check against the official notice below — it lists the full affected range.
McKesson Medical-Surgical Inc. is recalling Amoxicillin Capsules, USP, 500 mg in 100-count bottles manufactured by Sandoz Pharma due to current Good Manufacturing Practice (cGMP) deviations involving temperature abuse. The recall affects 12 bottles distributed nationwide across the United States. Because McKesson is unable to identify which specific lot numbers were received by particular customers, recall letters have been sent to affected consignees that include the distribution date and the dates when the impacted product may have been shipped to them.
The source does not specify what action affected consumers should take in response to this recall.
Written by software from the official notice below. Not reviewed by a lawyer.
cGMP deviations: Temperature abuse
Reason for recall: cGMP deviations: Temperature abuse Distribution: USA nationwide. Quantity: 12 bottles Lot/code info: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
Official record: FDA (Drug enforcement) ↗
Republished from the official source above; details can change — the source record controls.